CJC-1295 no DAC (5mg)

Research use only

CJC-1295 No DAC—also known as Modified GRF (1-29) or GHRH (1-29) analogue—is a synthetic peptide derivative of the first 29 amino acids of growth hormone-releasing hormone (GHRH). It mimics GHRH activity, stimulating the release of growth hormone in a pulsatile manner. Its lack of the DAC (Drug Affinity Complex) component results in a shorter half-life, making it suitable for experiments requiring precise dosing and temporal control in endocrine and metabolic research.

Modified GHRH (1-29) analogue for growth hormone secretion research

CJC-1295 No DAC—also known as Modified GRF (1-29) or GHRH (1-29) analogue—is a synthetic peptide derivative of the first 29 amino acids of growth hormone-releasing hormone (GHRH). It mimics GHRH activity, stimulating the release of growth hormone in a pulsatile manner. Its lack of the DAC (Drug Affinity Complex) component results in a shorter half-life, making it suitable for experiments requiring precise dosing and temporal control in endocrine and metabolic research.

Supplied as a lyophilized powder in vials (5 mg). For short-term storage, keep at room temperature protected from light. For long-term preservation, store at –20 °C, ideally under inert conditions. Upon reconstitution (e.g., in sterile water or buffered solution), aliquot and store at –20 °C, avoiding repeated freeze–thaw cycles.

Supplied as a lyophilized powder in vials (5 mg). For short-term storage, keep at room temperature protected from light. For long-term preservation, store at –20 °C, ideally under inert conditions. Upon reconstitution (e.g., in sterile water or buffered solution), aliquot and store at –20 °C, avoiding repeated freeze–thaw cycles.

For laboratory research use only. Not for human or veterinary use. Not a drug, food, or cosmetic.

Frequently bought together: DSIP (5 mg), Epitalon (10 mg), Frag 176-191 5mg